These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28216184)

  • 1. Vaccine development for emerging virulent infectious diseases.
    Maslow JN
    Vaccine; 2017 Oct; 35(41):5437-5443. PubMed ID: 28216184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
    Maslow JN
    Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine.
    Pregelj L; Hine DC; Oyola-Lozada MG; Munro TP
    Trends Biotechnol; 2020 Sep; 38(9):943-947. PubMed ID: 32600777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology.
    Gilbert SC; Warimwe GM
    Vaccine; 2017 Aug; 35(35 Pt A):4461-4464. PubMed ID: 28576573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development.
    Roberts CC
    Hum Vaccin Immunother; 2019; 15(10):2258-2263. PubMed ID: 31268394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rethinking the Response to Emerging Microbes: Vaccines and Therapeutics in the Ebola Era--a Conference at Harvard Medical School.
    Knipe DM; Whelan SP
    J Virol; 2015 Aug; 89(15):7446-8. PubMed ID: 25995250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.
    Bozzo J; Jorquera JI
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):585-604. PubMed ID: 28480779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.
    Wolf J; Hansen R; Hassis K; Lapps W; Warmuth E
    Vaccine; 2020 Oct; 38(46):7198-7200. PubMed ID: 33032845
    [No Abstract]   [Full Text] [Related]  

  • 9. Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential.
    Zumla A; Dar O; Kock R; Muturi M; Ntoumi F; Kaleebu P; Eusebio M; Mfinanga S; Bates M; Mwaba P; Ansumana R; Khan M; Alagaili AN; Cotten M; Azhar EI; Maeurer M; Ippolito G; Petersen E
    Int J Infect Dis; 2016 Jun; 47():5-9. PubMed ID: 27321961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.
    Siddharta A; Pfaender S; Vielle NJ; Dijkman R; Friesland M; Becker B; Yang J; Engelmann M; Todt D; Windisch MP; Brill FH; Steinmann J; Steinmann J; Becker S; Alves MP; Pietschmann T; Eickmann M; Thiel V; Steinmann E
    J Infect Dis; 2017 Mar; 215(6):902-906. PubMed ID: 28453839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivalent DNA Vaccines as A Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses.
    Jiang J; Ramos SJ; Bangalore P; Elwood D; Cashman KA; Kudchodkar SB; Schultheis K; Pugh H; Walters J; Tur J; Yan J; Patel A; Muthumani K; Schmaljohn CS; Weiner DB; Humeau LM; Broderick KE
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33673603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emerging infectious agents].
    Chidiac C; Ferry T
    Transfus Clin Biol; 2016 Nov; 23(4):253-262. PubMed ID: 27644171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV).
    Zumla A; Alagaili AN; Cotten M; Azhar EI
    BMC Med; 2016 Sep; 14(1):132. PubMed ID: 27604081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparing for Emerging Infectious Diseases in the Perinatal Population.
    O'Rourke K; Murphy T; Srinivas SK; Pegues DA
    J Obstet Gynecol Neonatal Nurs; 2018 Mar; 47(2):245-253. PubMed ID: 28736265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Funding vaccines for emerging infectious diseases.
    Wong G; Qiu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrative review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure.
    Errett NA; Sauer LM; Rutkow L
    Am J Disaster Med; 2019 Summer; 14(3):193-200. PubMed ID: 32421851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.
    Trovato M; Sartorius R; D'Apice L; Manco R; De Berardinis P
    Front Immunol; 2020; 11():2130. PubMed ID: 33013898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola and Zika: Cautionary tales.
    Osterholm MT
    Science; 2016 Sep; 353(6304):1073. PubMed ID: 27609862
    [No Abstract]   [Full Text] [Related]  

  • 19. MERS coronavirus outbreak: Implications for emerging viral infections.
    Al-Omari A; Rabaan AA; Salih S; Al-Tawfiq JA; Memish ZA
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):265-285. PubMed ID: 30413355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a vaccine against Ebola virus.
    Geisbert TW; Jahrling PB
    Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.